PBPH vs XBI: which is really different?

PBPH and XBI hold 14% of their weight in the same names. Portfolio Building Block World Pharma and Biotech Index ETF and State Street(R) SPDR(R) S&P(R) Biotech ETF.

PBPH costs 0.22 points a year less; XBI is 10.4 times larger.

PBPHXBI
Expense ratio0.13%0.35%
Net assets, PBPH as of Jul 31, 2026 and XBI as of Oct 8, 2026$952m$9.9bn
Total return, 1 yearnot published+45.0%
What it tracksBiotechBiotech
Holdings in common14%
S&P 500, total return, since Nov 25, 2025+16.6%
S&P 500, total return, 1 year+17.3%
Against the S&P 500, since Nov 25, 2025behind by 3.4 pts
Against the S&P 500, 1 yearahead by 27.7 pts
Below its all-time high11.1%, high on Feb 8, 2021

Holdings in common uses holdings dated Jul 31, 2026 and Oct 8, 2026.

59.2%
PBPH in the S&P 500
12.7%
XBI in the S&P 500
+13.2%
PBPH total return, since launch
+45.0%
XBI total return, 1 year
PBPH · 6 months to Oct 9, 202641% of its weight is outside the S&P 500
41% of its weight is outside the S&P 50059% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.59%41%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 95% · top ten 62% of the fund · 53 holdings as filed for Jul 31, 2026 · Nasdaq-100: 14% in41% of its weight is outside the S&P 50059% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.59%41%in the S&P 500outsideactive share 95% · Nasdaq-100: 14% in

59% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.

XBI · 1 year to Oct 9, 202687% of its weight is outside the S&P 500
87% of its weight is outside the S&P 50013% of XBI's weight is in S&P 500 companies and 87% is outside the index. Holdings as of Oct 8, 2026.13%87%inof its weight outside the S&P 500active share 98% · top ten 17% of the fund · 165 holdings as published by its issuer for Oct 8, 2026 · Nasdaq-100: 9% in87% of its weight is outside the S&P 50013% of XBI's weight is in S&P 500 companies and 87% is outside the index. Holdings as of Oct 8, 2026.13%87%inof its weight outside the S&P 500active share 98% · Nasdaq-100: 9% in

13% of XBI's weight is in S&P 500 companies and 87% is outside the index. Holdings as of Oct 8, 2026.

ETFIQ Off-Index Score · XBI scores higherHow much of it is not the index it is sold as an alternative to?
0.1, the lowest in this set92.3, the highest

A percentile among the 391 thematic ETFs with a holdings filing. All thematic ETFs ranked by it → How it is computed →

What they hold in common

By the books each fund has filed, PBPH and XBI hold 14% of their money in the same securities at the same weight. Above 50%, holding both is close to holding one of them twice. Holdings dated Jul 31, 2026 and Oct 8, 2026.

half

14% in common

Positions both hold, largest shared weight first
Holding PBPH XBI
ABBVIE INC 6.94% 1.65%
AMGEN INC 4.63% 1.58%
GILEAD SCIENCES INC 3.77% 1.53%
VERTEX PHARMACEUTICALS INC 2.82% 1.47%
REGENERON PHARMACEUTICALS INC 1.79% 1.39%
NATERA INC 0.85% 1.79%
REVOLUTION MEDICINES INC 0.77% 1.37%
BIOGEN INC 0.70% 1.57%
ALNYLAM PHARMACEUTICALS INC 0.63% 1.32%
INCYTE CORP 0.56% 1.36%
UNITED THERAPEUTICS CORP 0.51% 1.59%
INSMED INC 0.48% 1.18%
Only in PBPH
ELI LILLY & COMPANY 15.20%
JOHNSON & JOHNSON 9.66%
MERCK & COMPANY INC 5.04%
ROCHE HOLDING AG 4.74%
NOVARTIS AG 4.47%
ASTRAZENECA PLC 3.90%
NOVO NORDISK A/S 3.51%
PFIZER INC 3.33%
Only in XBI
TWIST BIOSCIENCE CORP 1.84%
HALOZYME THERAPEUTICS INC 1.55%
IOVANCE BIOTHERAPEUTICS INC 1.54%
TG THERAPEUTICS INC 1.48%
PROTAGONIST THERAPEUTICS INC 1.46%
KRYSTAL BIOTECH INC 1.43%
CRISPR THERAPEUTICS AG 1.41%
PTC THERAPEUTICS INC 1.40%

14% of the two portfolios are the same securities at the same weight.

Performance, window by window

Total returnvs the S&P 500vs the Nasdaq-100
WindowPBPHXBIPBPHXBIPBPHXBI
3 months+4.7%−3.3%+1.3 pts−6.7 pts+1.0 pts−7.0 pts
6 months+11.0%+18.9%−4.1 pts+3.8 pts−12.2 pts−4.3 pts
1 yearnot published+45.0%not published+27.7 ptsnot published+21.4 pts
3 yearsnot published+114.6%not published+28.8 ptsnot published+7.3 pts
Since launch
PBPH Nov 2025 · XBI Feb 2006
+13.2%+890.7%−3.4 pts+92.2 pts−10.8 pts−1,164.7 pts

Source: ETFIQ. Open the live comparison on ETFIQ →

On the same fields

PBPH
Portfolio Building Block World Pharma and Biotech Index ETF · Holds 53 stocks in biotech, 59% of its weight in S&P 500 companies
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF · Holds 165 stocks in biotech, 13% of its weight in S&P 500 companies
Theme Biotech Biotech
In the S&P 500 59.2% 12.7%
Active share vs the S&P 500 95.0% 98.4%
In the Nasdaq-100 14.1% 8.5%
Holdings 53 165
Top ten, share of the fund 61.9% 16.9%
Expense ratio 0.13% 0.35%
Fee for the differing part 0.14% 0.36%
Total return, 1 year +13.2% (since it first traded on Nov 25, 2025) +45.0%
vs the S&P 500 −3.4 pts +27.7 pts
vs the Nasdaq-100 −10.8 pts +21.4 pts
Below its high −4.8% −11.1%
Net assets, PBPH as of Jul 31, 2026 and XBI as of Oct 8, 2026 $952m $9.9bn

As of Oct 9, 2026. Source: ETFIQ.

PBPH in plain words

By weight, 59% of PBPH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 62% of the fund across 53 positions, as filed for Jul 31, 2026. Since it first traded on Nov 25, 2025 the fund returned +13.2% with distributions reinvested against +16.6% for the S&P 500, so a holder was behind by 3.4 pts.

XBI in plain words

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 17% of the fund across 165 positions, as published by its issuer for Oct 8, 2026. Over the year to Oct 9, 2026 the fund returned +45.0% with distributions reinvested against +17.3% for the S&P 500, so a holder was ahead by 27.7 pts. It sits 11.1% below its all-time high of Feb 8, 2021.

Questions people ask

Do PBPH and XBI hold the same stocks?
By their latest filings, 14% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, PBPH or XBI?
PBPH has 59% of its weight in S&P 500 names and XBI has 13%, so XBI differs more from the index.
Which is cheaper, PBPH or XBI?
PBPH charges 0.13% a year and XBI charges 0.35%, so PBPH is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from

ETFIQ links to the documents behind every figure; a link is not an endorsement. A comparison is not a recommendation.

How this is computed

It is a position in a set, not a rating, and neither end of it is a recommendation.

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed.

Every figure is an ETFIQ calculation with distributions reinvested.

Cite this page

ETFIQ, PBPH against XBI, data as of Oct 9, 2026. https://etfiq.com/compare/themes/pbph-vs-xbi

Open data

Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms.